LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $761,643 | +65.4% | 12,711 | +99.0% | 0.01% | +100.0% |
Q2 2023 | $460,431 | +879.6% | 6,386 | +1319.1% | 0.00% | – |
Q4 2019 | $47,000 | -19.0% | 450 | -22.1% | 0.00% | -100.0% |
Q3 2019 | $58,000 | +56.8% | 578 | +80.6% | 0.00% | – |
Q2 2019 | $37,000 | -2.6% | 320 | +6.7% | 0.00% | – |
Q1 2019 | $38,000 | -97.7% | 300 | -97.5% | 0.00% | -100.0% |
Q4 2018 | $1,628,000 | +16180.0% | 12,000 | +17042.9% | 0.02% | – |
Q4 2017 | $10,000 | +25.0% | 70 | +12.9% | 0.00% | – |
Q3 2017 | $8,000 | – | 62 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |